PDL BioPharma Plans To Divest Assets, Emerge As Pure Play Biotech
This article was originally published in The Pink Sheet Daily
Executive Summary
Sale of PDL’s lucrative royalty stream or even the company itself is not off the table as reorganization unfolds.